Research Identifies Potential Drug Treatment for Alzheimer's

Researchers have claimed that a compound which was developed to treat neuropathic pain has shown potential as an innovative treatment for Alzheimer's disease.

"Cleveland Clinic dedicated two years of research into the examination of this compound and our findings show it could represent a novel therapeutic target in the treatment of Alzheimer's disease," said Mohamed Naguib, M.D., Professor of Anesthesiology, Cleveland Clinic Lerner College of Medicine.

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

"Development of this compound as a potential drug for Alzheimer's would take many more years, but this is a promising finding worthy of further investigation."

In the study, the compound MDA7 induced beneficial immune responses that limited the development of Alzheimer's disease.

Treatment with the compound restored cognition, memory and synaptic plasticity - a key neurological foundation of learning and memory - in an animal model.

Diseases Related to Old Age
Ageing is referred to the accumulation of changes that brings a person closer to death.

The study has been published online in the Neurobiology of Aging.

Source-ANI

Mastinib as Add-on Treatment Improves Patients With Alzheimer's Disease
Masitinib has proved to be highly beneficial in treating mild to moderate Alzheimer’s disease. The prognosis was found to be better with masitinib as compared to placebo administration.

Donepezil may be Useful in Moderate-to-Severe Alzheimer's Disease
Donepezil, which is currently used in mild-to-moderate cases of Alzheimer’s disease, may be useful in severe cases as well, according to a recent study.